Imagen de Portada

Comparison of two doses of intravitreal bevacizumab (avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American collaborative retina study group at 6 months of follow-up

PURPOSE: To report the 6-month anatomical and visual outcomes after injecting two different doses of intravitreal bevacizumab in patients with macular edema secondary to branch retinal vein occlusion (BRVO). METHODS: An interventional, retrospective multicenter study of 45 eyes that were treated wit...

Descripción completa

Detalles Bibliográficos
Autores Principales: WU, LIHTEH, AREVALO, J FERNANDO, ROCA, JOSE A., MAIA, MAURICIO, BERROCAL, MARIA H., RODRIGUEZ, FRANCISCO J., EVANS, TEODORO, COSTA, ROGERIO A., CARDILLO, JOSE
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2008
Materias:
Bevacizumab
Triamcinolone
Angiogenesis inhibitor
Monoclonal antibody
Vasculotropin a
Adult
Aged
Article
Branch retinal artery occlusion
Ciliary disk
Clinical article
Clinical trial
Controlled study
Drug dose comparison
Female
Human
Laser coagulation
Male
Multicenter study
Retina macula edema
Retina neovascularization
Treatment outcome
Visual acuity
Vitrectomy
Comparative study
Drug antagonism
Fluorescence angiography
Follow up
Injection
Middle aged
Optical coherence tomography
Retina vein occlusion
Retrospective study
Vitreous body
Angiogenesis inhibitors
Fluorescein angiography
Follow-up studies
Humans
Injections
Macular edema
Retinal vein occlusion
Retrospective studies
Vascular endothelial growth factor a
Branch retinal vein occlusion
Vascular endothelial growth factor
optical coherence
monoclonal
Antibodies
Tomography
Acceso en línea:https://repository.urosario.edu.co/handle/10336/22934
https://doi.org/10.1097/IAE.0b013e3181619bee

Internet

https://repository.urosario.edu.co/handle/10336/22934
https://doi.org/10.1097/IAE.0b013e3181619bee

Ejemplares similares